Mr. Dolan has served on the Tufts University Board of Trustees since 2001 and was elected Chairman of the Board in November 2013. Before becoming Chairman, he served in several leadership capacities including Vice Chair of the Board, Chair of the Presidential Search Committee, and as chair or a member of the Compensation, Academic Affairs, Administration and Finance, Trusteeship and Audit Committees.
He joined Bristol-Myers Squibb in 1988 and after more than a decade leading the company’s Consumer Products, Nutritionals and Medical Device businesses, he was named CEO of the company in 2001 at age 45. Ushering the company into biologics in 2004, he licensed an immuno-oncology compound that became Yervoy, later named as the Biotech Discovery of the Decade for extending survival in some of the hardest to treat cancers. In 2006, he backed up the commitment with the largest capital investment in the company’s history to build the first Bristol-Myers Squibb biologics manufacturing facility. After his career at Bristol-Myers Squibb, he was Chairman and CEO of GeminX, a venture capital backed startup oncology firm that was successfully sold to Cephalon Pharmaceuticals.
Mr. Dolan has served on the boards of multiple for-profits and not-for-profits, including the American Express Company, ChildObesity180 and the Tuck School Board of Overseers at Dartmouth College. He currently serves as Vice Chair of the Board of Directors for The Partnership for a Healthier America. He is former Chairman of Allied Minds, an innovation company that forms, funds, manages and builds startups based on early-stage technology originating from U.S. universities and federally funded research institutions.
Mr. Dolan graduated magna cum laude from Tufts University in 1978 with a Bachelor of Arts degree majoring in Social Psychology. He then earned a Master of Business Administration degree from the Amos Tuck School of Business at Dartmouth College in 1980.